MD

Manorma Devi

Director Director DIN 06664747
DIN 06664747 First appointment Sep 2013 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Manorma Devi

Data last updated:

Manorma Devi was a Director at New Maurya Hospital Private Limited (2016–2017) and Director at Crysto Pharmaceuticals Private Limited (from 2013). The companies operate in Healthcare.

DIN 06664747
Primary Designation Director
Industry Healthcare
First Appointment 30 Sep 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
New Maurya Hospital Private Limited U85100BR2016PTC026050
Director22 Feb 20162016Strike Off
Director30 Sep 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Crysto Pharmaceuticals Private Limited
New Maurya Hospital Private Limited
Premium access

Shareholding and investment profile for Manorma Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manorma Devi

Manorma Devi was first appointed on 30 Sep 2013 as Director at Crysto Pharmaceuticals Private Limited. The most recent appointment on record is 22 Feb 2016 at New Maurya Hospital Private Limited.

Manorma Devi held 2 earlier board appointments: New Maurya Hospital Private Limited (Director, 22 Feb 2016 to 01 Dec 2017); Crysto Pharmaceuticals Private Limited (Director, from 30 Sep 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available